Upside, Downside Movers in the Morning

Upside

– $TCRT +25.0% (extends its surge after closing a PAH-focused biotech acquisition and securing about $350M of financing)

– $NCPL +19.0% (regains Nasdaq minimum-bid compliance)

– $SITC +18.0% (declares a $3.00 special cash distribution after an asset sale and plans to delist from the NYSE)

– $FFR +9.0% (launches the $2,490 FF Nova humanoid robot and outlines a proposed roughly $200M robotics combination)

– $ASM +6.5% (Roth/MKM upgrades to Buy from Neutral and raises its target to $8)

– $SMTC +4.0% (raises Q3 sales, operating-margin and EPS outlooks at its data-center analyst day)

– $TSLA +3.0% (unveils a redesigned Roadster featuring rocket-style thrusters)

– $STLA +3.0% (better-than-feared Q3 shipment update showed consolidated volumes down just 1% year over year)

– $FRO +3.0% (tanker shares rebound as geopolitical disruption continues to support shipping rates)

– $RBRK +3.0%, $VRNS +2.5% (cybersecurity names rise after VRNS agreed to a $6.3B all-cash acquisition)

– $NOK +2.5%, $AAOI +2.0% (networking and optical names gain after SMTC raised its data-center outlook)

Downside

– GUTS -53.0% (REMAIN-1 met its six-month co-primary endpoint, but 5.1% weight regain versus 8.2% for sham and a still-pending one-year co-primary fell short of elevated expectations)

– $JAGX -29.0% (special preferred-stock dividend was paid, with each preferred share set to convert into five common shares on November 2, intensifying dilution concerns)

– $MDXH -17.0% (suspends FY revenue guidance after preliminary Q3 revenue of about $22.7M)

– $TLK -15.0% (Indonesia ADR slumps after a warning that the country could face an emerging-market index downgrade)

– $CRWV -5.0%, $IREN -3.5%, $NBIS -2.5% (AI-infrastructure names extend their selloff on debt-funded buildout and profitability concerns)

– $TRV -4.0% (Q3 beat with lower-than-expected catastrophe losses, but shares sell the news after elevated expectations)

– $SKHY -3.5%, $SNDK -2.5%, $MU -2.5%, $ALAB -2.5%, $WDC -2.0%, $AMD -2.0% (chip and storage names weaken as the AI trade de-risks amid higher-rate concerns)

– $IONQ -2.5%, $ASTS -2.5% (speculative long-duration growth names weaken as rate-hike expectations rise)

– $MSTR -2.5%, $HUT -2.0%, $CRCL -1.5% (crypto-linked shares trade lower amid broad risk-off positioning)

Upside, Downside Movers in the Morning

Upside

– $VEEA +45.0% (regained full Nasdaq listing compliance following its reverse stock split)

– $XRTX +21.0% (outlined planned FDA IND and Health Canada clinical-trial filings for XRx-026 in gout)

– $SAIQ +19.5% (confirmed an October satellite launch advancing its post-quantum secure-communications roadmap)

– $HUM +14.5% (2027 CMS Star Ratings exceeded its top-quartile revenue goal, with its largest contract returning above the bonus-payment threshold)

– $CLOV +11.5% (PPO plans earned 5 stars and the HMO plan earned 4.5 stars for 2027, strengthening 2028 payment and enrollment economics)

– $CCI +9.5%, SBAC +7.0%, AMT +7.0% (tower operators rally as SPCX’s low-band spectrum deal implies a terrestrial buildout and potential new-tenant demand)

– $FSLY +7.0% (Oppenheimer upgrades to Outperform with a $35 target on AI-traffic growth)

– $AAOI +6.0%, LITE +6.0%, COHR +4.5%, GLW +3.5% (optical names rise after LITE said AI-data-center demand has booked component capacity through early 2029)

– $ECHO +5.0% (SPCX’s additional spectrum purchase reinforces the value of ECHO’s existing spectrum and equity partnership)

– $SPCX +4.0% (agrees to acquire a nationwide 800 MHz spectrum portfolio for about $8B, strengthening its direct-to-device mobile push)

Downside

– $ALHC -23.0% (key California HMO contract fell to 3.5 stars, below the CMS quality-bonus threshold)

– $TMUS -7.5%, T -6.5%, VZ -6.0% (wireless carriers slide as SPCX’s nationwide low-band spectrum acquisition raises the threat of direct mobile competition)

– ASTS -3.0% (falls after SPCX acquired spectrum ASTS had pursued, increasing competitive and spectrum-access concerns)

– $CVS -3.0% (only about 69% of Medicare Advantage members are in 4-star-plus plans for 2027, down from 81% for 2026)

– $AAPL -2.5% (no clear fresh catalyst identified; unusually large mega-cap decline despite higher Nasdaq futures)

– $DAL -1.5%, LUV -2.0%, $UAL -1.5% ($DAL missed Q3 profit expectations and sharply cut its FY outlook as surging fuel costs overwhelmed strong demand)

Upside, Downside Movers in the Morning

Upside

– $LPCN +40% (Health Canada approves TLANDO for testosterone replacement therapy)

– $APUS +9.4% (extends a high-volume rally tied to the BlockAssure agreement to build and operate the AssureChain insurance network)

– $PENG +4.3% (Q4 beat and FY27 sales and EPS outlook topped prior guidance and Street expectations on accelerating AI-infrastructure demand)

– CNQ +1.6%, APA +1.2%, OXY +1.0%, COP +1.0% (oil producers rise as crude climbs back above $100 a barrel)

Downside

– $CRBU -42% (launches a strategic-alternatives review, discontinues two allogeneic CAR-T programs and plans substantial workforce reductions)

– $BULL -30% (bipartisan House panel report says structural China ties pose national-security and US-user-data risks)

– $STM -5.4%, $TER -3.0%, $ASML -3.0%, $AMAT -2.7%, $LRCX -3.0%, $MU -2.8% (chip stocks fall in the risk-off technology tape as oil-driven inflation concerns pressure rate-sensitive growth shares)

– $BMNR -5.0%, $CRCL -4.0%, $MSTR -3.8%, $COIN -3.1%, $HOOD -3.0% (crypto-linked stocks fall as digital-asset prices weaken)

– $AAOI -4.8%, $CIEN -3.8%, $MTSI -3.0%, $COHR -3.2%, $GLW -3.3% (AI-networking and optical winners pull back after sharp recent rallies as technology exposure is reduced)

– $DB -4.7%, $SAN -4.2%, $HSBC -3.9%, $NWG -3.5%, $BCS -3.3% (European-bank ADRs fall as oil-driven inflation and sovereign-bond stress deepen fiscal concerns, with UK lenders also facing budget-tax fears)

– $STZ -3.9% (quarter beat, but adjusted FY guidance was merely reiterated and beer depletions declined)

– $BE -3.8%, $CEG -3.5%, $EME -1.9% (AI-power and data-center infrastructure winners give back part of recent gains amid the broader risk-off rotation)